See Also
See Again
Sickle cell disease: breakthrough with innovative new treatment
Kendrick Cromer completes groundbreaking gene therapy treatment
© Getty Images
Sickle cell disease is a condition little understood by most people around the world, despite it being the number one most common inherited disease in the world. This genetic blood disease can affect the most fundamental functions of an individual's body, leading to lifelong health challenges. Fortunately, recent medical advances have shed new light on the condition, leading to greater public awareness, increased research funding, and growing societal empathy.
In 2023, the US Food and Drug Administration (FDA) approved an innovative gene therapy treatment and 12-year-old Kendrick Cromer became the first person to receive it. After 44 days of treatment, Cromer left the hospital on October 21, 2024. It was an emotional celebration, for the doctors, nurses, family, and friends who supported him throughout his journey. Doctors believe the potentially life-changing treatment will make unprecedented improvements to his quality of life.
Click through the following gallery to learn more about sickle cell disease, current treatments, and why supporting those affected is so crucial.
RECOMMENDED FOR YOU
MOST READ
- Last Hour
- Last Day
- Last Week
-
1
CELEBRITY Relationships
-
2
HEALTH Viruses
-
3
LIFESTYLE Sports
-
4
CELEBRITY Paris 2024 olympics
-
5
LIFESTYLE Children
-
6
-
7
-
8
LIFESTYLE Housing
-
9
LIFESTYLE Existential crisis
What is purpose anxiety, and how can you tell if you have it?
-
10
LIFESTYLE Dating